Showing results (61-70 of 120) with videos related to
Sort By:
Pageof 12
Leukemia & Lymphoma|August 23, 2000
Accumulation of sestamibi in lymphoma cell lines in vitroM Kim, M V Gronda, H A Messner, et al.Magnetic Resonance Imaging|January 1, 1993
Mechanisms that contribute to the in vitro relaxation and signal intensity of water in barium sulfate suspensions used as MRI contrast agentsR W Briggs, T Liebig, J R Ballinger, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1993
Formulation of technetium-99m-aerosol colloid with improved delivery efficiency for lung ventilation imagingJ R Ballinger, T W Andrey, I Boxen, et al.Bioconjugate Chemistry|September 30, 1999
Convenient preparation of no-carrier-added technetium-99m radiopharmaceuticals using solid-phase technologyR Dunn-Dufault, A Pollak, J R Thornback, et al.Biochemical Pharmacology|October 6, 1997
Modifying the in vitro accumulation of BMS181321, a technetium-99m-nitroimidazole, with unlabelled nitroaromaticsT Melo, H A Hua, J R Ballinger, et al.International Journal of Cancer|March 23, 2000
The influence of expression of P-glycoprotein on the penetration of anticancer drugs through multicellular layersJ K Tunggal, T Melo, J R Ballinger, et al.Clinical Nuclear Medicine|June 1, 1992
'Reverse crescent pattern' on SPECT brain perfusion scan in chronic subdural hematomaH Toyama, M Ichise, B I Schacter, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 20, 2000
Normal patterns on 99mTc-ECD brain SPECT scans in adultsF Tanaka, D Vines, T Tsuchida, et al.Clinical Nuclear Medicine|June 1, 1990
Cerebral perfusion imaging with technetium-99m HMPAO following cerebral trauma. Initial experienceR H Reid, K Y Gulenchyn, J R Ballinger, et al.Pageof 12